This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buffolano, W.
Right arrow Articles by Gargano, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buffolano, W.
Right arrow Articles by Gargano, N.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, December 2005, p. 5916-5924, Vol. 43, No. 12
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.12.5916-5924.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Use of Recombinant Antigens for Early Postnatal Diagnosis of Congenital Toxoplasmosis

Wilma Buffolano,1,{dagger} Elisa Beghetto,2,{dagger} Mariassunta Del Pezzo,1 Andrea Spadoni,2 Manlio Di Cristina,2 Eskild Petersen,3,4 and Nicola Gargano2*

Department of Pediatrics, Federico II University, Naples, Italy,1 Kenton Laboratories, Rome, Italy,2 Department of Infectious Diseases, Aarhus University Hospital, Skejby, Denmark;,3 Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden4

Received 30 May 2005/ Returned for modification 24 August 2005/ Accepted 27 September 2005

The main objective of this work was to improve the early serologic diagnosis of toxoplasmosis in children at risk of congenital infection by using recombinant antigens. Serum samples from 104 infants born to mothers with primary Toxoplasma gondii infection acquired during pregnancy, of which 35 were congenitally infected and 22 had clinical silent toxoplasmosis at birth, were included. Immunoglobulin M (IgM), IgG, and IgG subtype antibodies against epitopes carried by fragments of T. gondii MIC2, MIC3, MIC4, M2AP, AMA1, and SAG1 gene products were measured by performing parallel enzyme immunoassays (Rec-ELISAs). Recombinant antigens preferentially reacted with IgG antibodies from infected infants compared to uninfected subjects (P < 0.0001), indicating that sera from infected children recognized a more diverse repertoire of antigens than sera transferred over the placenta from the mothers. Using two serial samples collected within 3 months of life, it was possible to demonstrate a neosynthesis of specific anti-MIC2 and anti-SAG1 immunoglobulin G, mainly of the IgG2 subtype, in 13 out of 20 infants with congenital toxoplasmosis. IgM antibodies in 97% of infected infants reacted with at least one of the recombinant antigens, confirming the diagnosis of congenital infection as soon as 2 months after birth (P < 0.0001). The use of recombinant antigens is effective in distinguishing T. gondii-infected from uninfected infants and shows that assays based on recombinant antigens improve the diagnosis of newborns with congenital toxoplasmosis.


* Corresponding author. Mailing address: Kenton Laboratories, Via Pontina km 30.400, 00040 Rome, Italy. Phone: 39-06-91611494. Fax: 39-06-91629012. E-mail: gargano{at}kenton.it.

{dagger} These authors contributed equally to this work.


Journal of Clinical Microbiology, December 2005, p. 5916-5924, Vol. 43, No. 12
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.12.5916-5924.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Beghetto, E., Spadoni, A., Bruno, L., Buffolano, W., Gargano, N. (2006). Chimeric Antigens of Toxoplasma gondii: Toward Standardization of Toxoplasmosis Serodiagnosis Using Recombinant Products.. J. Clin. Microbiol. 44: 2133-2140 [Abstract] [Full Text]